Algae produce compounds that can relieve pain and inflammation.
What if we could develop functional food and medication from these natural molecules?
Dive into the world of algae research
Over
6.8 million people
suffer from inflammatory bowel disease (IBD),
a persistent and painful inflammation that damages the digestive tract.
Yet, no effective cure exists...
uses the health potential of algae to bring relief for IBD patients.
At Algae4IBD, we study algae and their metabolites to develop novel solutions for the prevention and treatment of pain, inflammation, and IBD.
Latest news
Learn more about algae and its potential
We aim to deliver our solutions by mid-2025
Our approach considers patients, health care systems, society, and companies – for the benefit of all.
21 partners from 11 countries
Because innovation needs more than one bright mind.
Microbiologists, physicians, food developers and pharma SMEs have paired up in Algae4IBD. Sharing our expertise across disciplines and borders, we pursue a cutting-edge approach that shortens the development time from research to market from 10 to 4 years!
Our priority is the well-being of people who suffer from IBD!
Want to connect or have a question?
Get in touch with us!
Project Coordinator
Dr. Dorit Avni
- Migal Galilee Research Institute
- Mail: dorita@migal.org.il
- Phone +972 54-9815556
Media, Press and Communication
Dr. Melanie Maria Obermeier
- European Science Communication Institute
- Mail: mo@esci.eu
- Phone: +49 159 0450 2223
This project has received funding from the European Union‘s Horizon 2020 Research and Innovation programme under grant agreement N° 101000501